Literature DB >> 16078151

Inhibitory effects of various beverages on ritodrine sulfation by recombinant human sulfotransferase isoforms SULT1A1 and SULT1A3.

Haruka Nishimuta1, Masayuki Tsujimoto, Kenichiro Ogura, Akira Hiratsuka, Hisakazu Ohtani, Yasufumi Sawada.   

Abstract

PURPOSE: Ritodrine is known to undergo extensive presystemic sulfation in the intestinal mucosa, and its bioavailability is as low as 30%. Accordingly, inhibition of intestinal sulfation may lead to an increase in the bioavailability of ritodrine. In this study, we aimed to investigate the activities of ritodrine sulfation by SULT1A1, which is expressed predominantly in the liver, and SULT1A3, which is expressed predominantly in the intestine, as well as the inhibitory effects of beverages on their activities.
METHODS: We investigated ritodrine sulfation by using recombinant human sulfotransferase (SULT) 1A1 and SULT1A3 in an in vitro study. Next, we investigated the inhibitory effects of grapefruit juice, orange juice, green tea, and black tea on ritodrine sulfation.
RESULTS: Sulfation of ritodrine by SULT1A3 was much higher than that by SULT1A1, suggesting that the bioavailability of ritodrine may be limited by intestinal SULT1A3. The ritodrine sulfation activities of SULT1A1 and SULT1A3 were significantly inhibited by all beverages examined at a concentration of 10%. Green tea and black tea exhibited potent inhibition; even at a concentration of 5%, they both inhibited SULT1A1 by 100% and SULT1A3 by >or=95%.
CONCLUSION: Our results suggest that concomitant ingestion of beverages such as green tea and black tea may increase the bioavailability of orally administered ritodrine, and perhaps other beta2-agonists, and lead to an increase in the clinical effects or adverse reactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16078151     DOI: 10.1007/s11095-005-5263-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-09-15       Impact factor: 15.470

2.  Differential distribution of phenol and catechol sulphotransferases in human liver and intestinal mucosa.

Authors:  M Cappiello; L Giuliani; G M Pacifici
Journal:  Pharmacology       Date:  1990       Impact factor: 2.547

3.  Expression and characterization of a novel thyroid hormone-sulfating form of cytosolic sulfotransferase from human liver.

Authors:  J Wang; J L Falany; C N Falany
Journal:  Mol Pharmacol       Date:  1998-02       Impact factor: 4.436

4.  Assay of sulfotransferases.

Authors:  R D Sekura; C J Marcus; E S Lyon; W B Jakoby
Journal:  Anal Biochem       Date:  1979-05       Impact factor: 3.365

5.  Human gastrointestinal sulfotransferases: identification and distribution.

Authors:  Guangping Chen; Daqing Zhang; Nin Jing; Shuhua Yin; Charles N Falany; Anna Radominska-Pandya
Journal:  Toxicol Appl Pharmacol       Date:  2003-03-15       Impact factor: 4.219

6.  Ritodrine sulphation in the human liver and duodenal mucosa: interindividual variability.

Authors:  G M Pacifici; M C Quilici; B Giulianetti; R Spisni; M Nervi; L Giuliani; R Gomeni
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jan-Mar       Impact factor: 2.441

7.  Cardiac stimulation during ritodrine hydrochloride tocolytic therapy.

Authors:  J D Hosenpud; M J Morton; J P O'Grady
Journal:  Obstet Gynecol       Date:  1983-07       Impact factor: 7.661

8.  Solvent effect on cDNA-expressed human sulfotransferase (SULT) activities in vitro.

Authors:  Bennett Ma; Magang Shou; Michael L Schrag
Journal:  Drug Metab Dispos       Date:  2003-11       Impact factor: 3.922

9.  Method for determining the content of catechins in tea infusions by high-performance liquid chromatography.

Authors:  W E Bronner; G R Beecher
Journal:  J Chromatogr A       Date:  1998-05-01       Impact factor: 4.759

10.  Structural determination of the conjugated metabolites of ritodrine.

Authors:  W T Brashear; B R Kuhnert; R Wei
Journal:  Drug Metab Dispos       Date:  1990 Jul-Aug       Impact factor: 3.922

View more
  5 in total

1.  S-ketamine concentrations are greatly increased by grapefruit juice.

Authors:  Marko A Peltoniemi; Teijo I Saari; Nora M Hagelberg; Kari Laine; Pertti J Neuvonen; Klaus T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  2012-06       Impact factor: 2.953

2.  High accuracy in silico sulfotransferase models.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

3.  Sulfation of ritodrine by the human cytosolic sulfotransferases (SULTs): Effects of SULT1A3 genetic polymorphism.

Authors:  Ying Hui; Ming-Cheh Liu
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

Review 4.  The effect of grapefruit juice on drug disposition.

Authors:  Michael J Hanley; Paul Cancalon; Wilbur W Widmer; David J Greenblatt
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01-22       Impact factor: 4.481

Review 5.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.